Zenbexus PFS Data Suggest Utility In Community Treatment Of Multiple Myeloma Scrip Pharma Intelligence 5d
Bristol Myers Squibb’s Zenbexus Delivers Major Blood Cancer Win, Cuts Progression Risk 51% Benzinga 5d Article paywall
BMS gains two pivotal trial wins in lung disease and rare cancer Clinical Trials Arena 10h All sources
Bristol Myers Squibb’s Zenbexus delivers major blood cancer win, cuts progression risk 51% Benzinga 5d Zenbexus Article paywall
Bristol Myers Squibb secures expanded US approval for Camzyos Pharmaceutical Business Review 10:52 Thu, 01 Oct
Biotech’s rebound reality: Surging m&a deals meet deep retail skepticism ETF Trends 21h Biotechnology
Biopharma financings approach $100B as capital raises outpace 2025 BioWorld 1d Biotech Article paywall
Pharma giant GSK to expand in upper merion, investing $800 million Patch 1d GSK Biotechnology Biotech
